Marliesexeltis 0.02 mg - 3 mg (ethinylestradiol 0,02 mg + drospirenon 3 mg tablet (or.) (I) + placebo tablet (or.) (II)) · CNK 3105442

Product information

Marliesexeltis 0.02 mg - 3 mg
3 x 28 (24 + 4)
ethinylestradiol 0,02 mg + drospirenon 3 mg tablet (or.) (I) + placebo tablet (or.) (II)
3105442
0.35 / 10
Locked

Product properties

57-63-6
G03AA12
Exeltis Germany
Film-coated tablet
BE444272
05099151911155
M2
Public
444272-02

Pharmacist Assessment

Product permanently unavailable

Commercialization has been stopped (reason: Other reason) and the product is no longer available from wholesalers (score 0.35/10). Switching to an alternative is necessary.

Recommended alternative

Equivalent products

Tier A: Direct equivalents

Tier B: Galenic alternatives

Tier C: Strength alternatives

Tier D: ATC equivalents (parallel import)

Tier E: Active substances (magistral)

Stock overview

Availability in Freemium
  • 1 of 18 warehouse locations have stock
  • 1 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Commercialization stopped Active
- present

Other reason

Alternative available

Composition

6 ingredients

Substance Type Strength CAS
Active ingredient
0.02 mg
57-63-6
Active ingredient
3 mg
67392-87-4
Excipient
44 mg
Excipient
0.9 mg
Active ingredient
Excipient
89.5 mg

Additional information

View on BCPI

Availability statistics

Commercialization stopped
268 days
3
0
06/03/2026